Actavis Settles With Medicis Over Skin Drug Generic Plans
Actavis Inc. has agreed to a settlement with Medicis Pharmaceutical Corp., ending two Delaware federal patent infringement suits over its planned generic versions of two Medicis skin disease treatments, the companies...To view the full article, register now.
Already a subscriber? Click here to view full article